Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors

NCT07651020 is registered in ClinicalTrials.gov with Union Hospital, Tongji Medical College, Huazhong University of Science and Technology as lead sponsor.

NCT NCT07651020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07651020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase
Observational
Overall status
Completed
Start date
March 1, 2025
Completion date
February 28, 2026
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal cancer, glioblastoma, head and neck cancers, lung cancer, melanoma, ovarian cancer, pancreatic cancer, sarcoma